Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2026 ∙ Pinandyo, S. H. Ali, S. Aurelio, B. Amoah, A. S. Kaisar, M. M. M.

The association of helminth infection against antimalarial antibody responses in malaria infection and vaccination: a systematic review and meta-analysis

  • All age groups
  • Malaria
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Shahid, F. Farooq, H. Abeer, H. Mahmood, G. M. Sheikh, H. Ameer, M. Z. Fatima, L. Ameer, F. Amjad, Z. Ahmad, T. Z. Rehman, G. Rehman, A. U.

The Association of Polymyalgia Rheumatica and Giant Cell Arteritis With COVID-19 Vaccination: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Wei, M. Liu, L. Zhou, K. Li, Y.

The benefits of influenza vaccination in patients with cardiovascular disease: a systematic review and meta-analysis

  • All age groups
  • Influenza
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2026 ∙ Rahman, L. Gao, T. Nam, J. Zeng, Y. Li, G. Zeng, W.

The effect of digital interventions on the uptake of HPV vaccination in the United States: A systematic review and meta-analysis

  • Americas
  • United States of America
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Su, S. Jia, M. Song, Q. Guo, L. Peng, N. Yu, Y. Jiang, Y. Ji, F. Zou, Z. Zhang, L.

The hepatitis B care cascade among key populations towards global elimination: a systematic review and meta-analysis

  • Adults
  • Older adults
  • Hepatitis B
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Lihemo, G. Blunt, M. Dadari, I. Underwood, T. Ochoa Toasa, A. E. Velias, A. Hopkins, K. L. Thomson, A. Kanwagi, R. Gillespie, A. Pokharel, D. R. Singh, S.

The impact of COVID-19 on general vaccine acceptance in low- and middle-income countries: a systematic review

  • All age groups
  • Low and Middle Income Countries
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Kling, K. Falman, A. Branke, L. Ramharter, M. Rothe, C. Schonfeld, C. Grunewald, T.

Vaccination against chikungunya - a systematic review on the immunogenicity, tolerability, and safety of the live-attenuated vaccine (LAV) Ixchiq and the virus like particle (VLP) vaccine Vimkunya

  • All age groups
  • Chikungunya
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
High
2026 ∙ Pascucci, D. Lontano, A. Crovella, S. Cosci, S. Laurenti, P.

Vaccination coverage among individuals receiving HIV pre-exposure prophylaxis (PrEP): A systematic review and meta-analysis

  • All age groups
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Alhumaid, S. Alkhars, O. Algrafi, A. S. Dossary, N. A. Elhaj, N. Majzoub, R. A. Turkistani, J. A. Alhumaid, S. M. Shaikh, H. A. A. Aldiaram, A. Alahmed, A. H. Alomran, S. A. AlQatifi, M. B. Alkolib, M. J. Almubarak, M. S. Al-Helal, H. Alhaddad, A. J. Alsouaib, H. A. Albahrani, A. A. Aldera, A. H. Alnasser, F. M. Alhmeed, N. Alsulaiman, M. S. Al Alawi, Z. Alghazal, H. A.

Vaccine effectiveness across the Omicron evolutionary spectrum (BA.2, BA.5, XBB, JN.1, KP.3): a systematic review of studies published 2022-2025

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
High
2026 ∙ Lertussavavivat, T. Isaranuwatchai, S. Eiam-Ong, S. Praditpornsilpa, K. Susantitaphong, P.

Vaccine efficacy in CKD patients not on dialysis: a systematic review and meta-analysis

  • Adults
  • Older adults
  • Hepatitis B
  • COVID-19
  • Influenza
  • Pneumococcal disease
  • Herpes zoster
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
Loading...